Search

Consensus $7.61. The company said, 'This guidance includes an update to the company's Pharmaceutical and Specialty Solutions segment profit outlook to 4% to 6% growth, from 1% to 3% growth. [...]

UBS analyst Kevin Caliendo raised the firm's price target on Cardinal Health to $78 from $61 and keeps a Buy rating on the shares. The company's Pharma segment and the [...]

Through the 1990s, many of the companies in the medical supplies industry achieved growth through research and development and market expansion. The acquistion of companies now appears to be the favorite means to achieve growth. This trend is expected to continue for the next two years. Investors are encouraged to select companies having a well rounded product base.

Prices and earnings in the medical supplies industry have been under pressure in the late 1990s from government insurance agencies, such as Medicare, and competition within the industry. Reaearch and development, technological innovation, and industry consolidation are some of the methods by which medical supply companies have attempted to cope with the situation. Investors need to consider safety and timeliness factors when evaluating these stocks for selection.

Automation in medicine is the most notable trend in the medical supplies industry during the 1990s. Electrophysiology is the area where the greatest advances have been made in the last four years, along with new therapeutic delivery systems. New products and a weak dollar have kept these issues favorable. Medical supplies stocks are expected to show 10%-15% earnings growth, stable margins, and rising sales.

Several medical supplies stocks are expected to outperform the market through 1996. Hospitals are cutting costs, reducing capital expenses for equipment, and are entering exclusive contracts for supplies. However, revenue and earnings for both manufacturers and distributors will increase, in spite of the slowing international economies and higher interest rates. Investors need to evaluate these stocks' timeliness.

The medical supplies industry saw sales increase 7.2% during the 12 months ended Sep 30, 1994. During the same period, hospital admissions and outpatient visits rose 0.9% and 7.9%, respectively. Regulatory changes are anticipated that would increase the cost of clinical trials, reduce product liability, and allow the export of drugs and medical devices without the approval of the Food and Drug Administration.

Stocks in the medical supplies industry are expected to perform well out to 1998-2000. The loss of tax benefits for many companies in Puerto Rico should be countered by higher sales from new products and services during 1995. Potential long-term investors should examine timeliness and safety ranks for particular companies especially carefully, although the industry as a whole is expected to do well.

Medical supplies industry stocks are forecasted to perform well both during 1994-1995 and out to 1997-1999. The optimism is due to current market conditions and the slow pace at which national health care reform is being enacted. Under the eventual standardization of health care, companies with large market shares, with products in strong demand by consumers, with multiple product lines, and large distributors will be especially well poised for profit.

Healthcare reform could be a double-edged sword for medical supplies stocks. Federal cutbacks in research and development, delays in the product approval process and managed care are all combining to reduce prices and profits. On the other hand, reform is creating opportunities in new areas, such as home health care. New products will make 1995 a better investment year than 1994.

Prospective investors in the medical supplies industry should carefully watch the debate in Congress over health care reform. The redefinition of the marketplace will probably limit sales during 1994 and 1995 but could produce gains in the long term. Medical supplies companies are conducting studies to find which medical procedures will yield highest results at low cost. Business in overseas markets, particularly South America and the Pacific Rim, will likely expand in the long term.

Cardinal to lay off 4,200 and close 25 facilities worldwide By DON LONG Medical Device Daily Managing Editor Following the consolidation, comes the restructuring - including layoffs. It's a fairly [...]

Cardinal Health Inc.'s profit in the quarter ended Sept. 30 fell 7.2 percent because of merger expenses and accounting changes. The Dublin-based drug distributor and health care services provider said [...]

DUBLIN, Ohio -- Aided by a strong fourth quarter, Cardinal Health Inc. notched record revenues and earnings during fiscal 2001. The pharmaceutical distributor and corporate parent of Medicine Shoppe International [...]

Greater Columbus public companies RANKED BY 2000 REVENUE REVENUE 1: NET COMPANY NAME 2000/ INCOME ADDRESS 1999 (LOSS): CITY, ZIP 2000/ PHONE 1999 1 Cardinal Health Inc. $38.66 $857.4 7000 [...]

DUBLIN, Ohio -- Cardinal Health Inc., the corporate parent of Medicine Shoppe International Inc., reported record sales and earnings before special items during the three months ended March 31. But [...]

Cardinal Health Inc. has decided to increase the company's quarterly dividend by 25 percent to 2.5 cents a share. Cardinal Health split its shares 3-for-2 in April, making the dividend [...]

Cardinal Health Inc. has declared a regular quarterly dividend of $0.03 per share, payable April l5 no shareholders of record April 1. It is the 66th consecutive regular quarterly dividend [...]

DUBLIN, Ohio -- Cardinal Health Inc. registered record revenues and earnings for the second quarter of fiscal 2001. Over the three months ended December 31 the Medicine Shoppe International parent [...]

DUBLIN, Ohio -- Cardinal Health, in the midst of its bid to acquire competitor Bindley Western Industries, reported record revenues, earnings and return on capital for its second quarter ended [...]

DUBLIN, Ohio -- Packing up from where it left off in fiscal 2000, Cardinal Health Inc. began the current year with strong growth in earnings and revenues. Net income for [...]

DUBLIN, Ohio -- Cardinal Health Inc. ended the fourth quarter and 12 months of fiscal 2000 with record sales and earnings. The corporate parent of Medicine Shoppe International Inc. (MSI) [...]

Cardinal Health Inc. reported record earnings and revenue for its fourth quarter and fiscal year. Earnings per diluted share rose 24 percent to a record $0.72. from $0.58. Net earnings [...]

DUBLIN, Ohio -- With its business fundamentals clicking and a major reduction in merger-related costs, Cardinal Health Inc. saw its bottom line more than double during fiscal 2000's third quarter. [...]

Cardinal Health Inc. reported net earnings rose to a record $199 million from $161 million in 1999. Earnings per diluted share rose 25 percent to a record $0.70 from $0.56 [...]

Parent companies & combo operators Current Previous close close Net % 3/21/00 3/7/00 change change Ahold (combos) 25 7/16 22 15/16 + 2 1/2 +10.9 Albertson's (osco, sav-on, combos) 28 [...]

DUBLIN, Ohio -- With its pharmaceutical distribution unit producing record operating results, Cardinal Health Inc. scored a 22.6% bottom-line advance during this year's second quarter. Net income for the corporate [...]

Dublin-based Cardinal Health Inc. reported record second-quarter income and revenue. The health-care services provider said net earnings rose to a record $177 million, or 62 cents a share, from $141 [...]

DUBLIN. Ohio -- With strong performances across its various business units, Cardinal Health Inc., the corporate parent of Medicine Shoppe International Inc. (MSI), started fiscal 2000 in record fashion. The [...]

Cardinal Health has declared a regular quarterly dividend of 2.5 cents per common share, payable Jan. 15 to shareholders of record as of Jan. [...]

Cardinal Health Inc. reported a record net income of $152 million in the first quarter ended Sept. 30, up 24 percent from a year earlier. Earnings per share rose 23 [...]

Cardinal Health Inc. estimates earnings for its first quarter and full year of fiscal 2000 to climb 23 percent over 1999's figures. The Dublin-based health-care services provider expects earnings of [...]

DUBLIN, Ohio -- Buoyed by a strong performance in the fourth quarter, Cardinal Health Inc. produced a 7.3% bottom-line gain during fiscal 1999 after overcoming significant special charges. Net income [...]

DUBLIN, Ohio -- With strong demand across all three of its customer segments, Cardinal Health Inc. reported record earnings before special items during the third quarter of fiscal 1999. After-tax [...]